CLINICAL_TRIALS
trial_result
· 2022-10-12
Clinical Trial Update: HepaSphere™ Microspheres Prospective Registry
Summary
Prospective registry study update for HepaSphere microspheres in metastatic colorectal cancer has been completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merit Medical Systems, Inc. | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED | Results posted: 2022-10-12